| |
|
|
| Name: |
Bain Capital Life Sciences Investors LLC |
| City: |
BOSTON |
| State: |
MA |
| Zip: |
02116 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
28 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
NAMS |
Newamsterdam Pharma Ord Shs |
1 |
- |
$0.00 |
$247,708,000 |
10,473,913 |
19.91% |
130,714,000 |
0 |
12.842 |
N/A |
|
|
NUVL |
Nuvalent, Inc. |
2 |
- |
$0.00 |
$202,538,000 |
2,697,267 |
16.28% |
-60,713,000 |
-880,000 |
4.101 |
N/A |
|
|
DNTH |
Dianthus Therapeutics Ord Shs |
3 |
New |
$0.70 |
$89,761,000 |
2,992,028 |
7.21% |
89,761,000 |
2,992,028 |
20.189 |
N/A |
|
|
IRON |
Disc Medicine, Inc |
4 |
- |
$33.35 |
$82,010,000 |
1,317,213 |
6.59% |
5,042,000 |
-15,332 |
5.457 |
N/A |
|
|
KYTX |
Kyverna Therapeutics |
5 |
New |
$12.43 |
$78,590,000 |
3,163,868 |
6.32% |
78,590,000 |
3,163,868 |
7.358 |
N/A |
|
|
PHVS |
Pharvaris N V Ord Shs |
6 |
- |
$0.00 |
$76,341,000 |
3,303,381 |
6.14% |
-33,175,000 |
-600,938 |
7.977 |
N/A |
|
|
SVRA |
Savara Inc |
7 |
- |
$4.17 |
$72,536,000 |
14,565,457 |
5.83% |
5,642,000 |
332,706 |
10.762 |
Biotechnology |
|
|
ANNX |
Annexon, Inc. |
8 |
- |
$0.00 |
$62,402,000 |
8,703,268 |
5.02% |
25,802,000 |
641,549 |
10.109 |
N/A |
|
|
SLDB |
Solid Biosciences Inc |
9 |
- |
$7.81 |
$53,741,000 |
4,034,582 |
4.32% |
34,520,000 |
904,160 |
20.627 |
N/A |
|
|
MDGL |
Madrigal Pharmaceuticals Inc |
10 |
- |
$234.85 |
$52,606,000 |
196,995 |
4.23% |
-22,504,000 |
-127,624 |
0.998 |
Diagnostic Substances |
|
|
MRSN |
Mersana Therapeutics, Inc. |
11 |
- |
$2.47 |
$38,813,000 |
8,663,673 |
3.12% |
18,713,000 |
0 |
7.185 |
N/A |
|
|
CABA |
Cabaletta Bio, Inc. |
12 |
- |
$0.00 |
$27,592,000 |
1,617,364 |
2.22% |
-17,808,000 |
-382,636 |
3.145 |
N/A |
|
|
XFOR |
X4 Pharmaceuticals Inc |
13 |
- |
$0.90 |
$23,513,000 |
16,915,784 |
1.89% |
9,329,000 |
0 |
10.112 |
N/A |
|
|
TNGX |
Tango Therapeutics Ord Shs |
14 |
- |
$0.00 |
$22,968,000 |
2,892,663 |
1.85% |
-5,669,000 |
0 |
2.836 |
N/A |
|
|
ARQT |
Arcutis Biotherapeutics, Inc. |
15 |
- |
$9.08 |
$19,936,000 |
2,011,687 |
1.6% |
10,246,000 |
-988,313 |
1.889 |
N/A |
|
|
NRIX |
Nurix Therapeutics, Inc. |
16 |
- |
$0.00 |
$16,646,000 |
1,132,397 |
1.34% |
-2,166,000 |
-690,486 |
2.407 |
N/A |
|
|
SYRS |
Syros Pharmaceuticals, Inc. |
17 |
- |
$5.15 |
$14,711,000 |
2,749,808 |
1.18% |
-6,710,000 |
0 |
4.893 |
N/A |
|
|
MRNS |
Marinus Pharmaceuticals Inc |
18 |
- |
$1.30 |
$12,596,000 |
1,393,380 |
1.01% |
-2,960,000 |
-37,678 |
2.503 |
N/A |
|
|
AVIR |
Atea Pharmaceuticals, Inc. |
19 |
- |
$0.00 |
$10,042,000 |
2,485,638 |
0.81% |
2,461,000 |
0 |
3.009 |
N/A |
|
|
CCCC |
C4 Therapeutics, Inc. |
20 |
- |
$0.00 |
$9,332,000 |
1,142,210 |
0.75% |
54,000 |
-500,000 |
2.318 |
N/A |
|
|
RPID |
Rapid Micro Biosystems, Inc. |
21 |
- |
$0.82 |
$8,182,000 |
8,434,560 |
0.66% |
1,940,000 |
0 |
24.808 |
N/A |
|
|
ADGI |
Adagio Therapeutics, Inc. |
22 |
- |
$2.01 |
$7,990,000 |
1,799,595 |
0.64% |
357,000 |
-137,612 |
1.618 |
N/A |
|
|
NAUT |
Nautilus Biotechnology, Inc |
23 |
- |
$2.64 |
$5,880,000 |
2,000,000 |
0.47% |
-100,000 |
0 |
1.612 |
N/A |
|
|
ACRS |
Aclaris Therapeutics, Inc. |
24 |
- |
$1.18 |
$3,720,000 |
3,000,000 |
0.3% |
45,000 |
-500,000 |
4.052 |
N/A |
|
|
XLO |
Xilio Therapeutics, Inc. |
25 |
- |
$0.00 |
$3,030,000 |
2,805,413 |
0.24% |
1,487,000 |
0 |
10.519 |
N/A |
|
|
TSVT |
2seventy Bio, Inc. |
28 |
Closed |
$0.00 |
$0 |
0 |
0% |
-5,687,000 |
-1,331,801 |
0 |
N/A |
|
|
NTRA |
Natera, Inc. |
26 |
Closed |
$107.51 |
$0 |
0 |
0% |
-25,068,000 |
-400,197 |
0 |
N/A |
|
|
RVMD |
Revolution Medicines, Inc. |
27 |
Closed |
$38.13 |
$0 |
0 |
0% |
-31,904,000 |
-1,112,396 |
0 |
N/A |
|
